Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Experimental Cell Research|July 26, 2016
Perturbation of the Warburg effect increases the sensitivity of cancer cells to TRAIL-induced cell deathMinami Kumazaki, Haruka Shinohara, Kohei Taniguchi, et al.
Cancer Science|October 4, 2016
MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1Taro Sugiyama, Kohei Taniguchi, Nobuhisa Matsuhashi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 12, 2017
Regulated Polarization of Tumor-Associated Macrophages by miR-145 via Colorectal Cancer-Derived Extracellular VesiclesHaruka Shinohara, Yuki Kuranaga, Minami Kumazaki, et al.
Hinyokika Kiyo. Acta Urologica Japonica|December 25, 2015
[Idiopathic Lumbar Hernia: A Case Report]Takuya Tsujino, Teruo Inamoto, Tomohisa Matsunaga, et al.
Oncotarget|April 6, 2017
MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cellsKoichiro Minami, Kohei Taniguchi, Nobuhiko Sugito, et al.
Molecular Therapy. Methods & Clinical Development|March 27, 2019
Anti-cancer Effects of a Chemically Modified miR-143 on Bladder Cancer by Either Systemic or Intravesical TreatmentYuki Yoshikawa, Kohei Taniguchi, Takuya Tsujino, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2019
Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 functionBin Gui, Fu Gui, Tomoaki Takai, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2019
Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In VivoTomoaki Takai, Takuya Tsujino, Yuki Yoshikawa, et al.
Oncotarget|January 20, 2018
The systemic inflammation-based Glasgow Prognostic Score as a powerful prognostic factor in patients with upper tract urothelial carcinomaTeruo Inamoto, Hideyasu Matsuyama, Shigeru Sakano, et al.
Journal of Medical Case Reports|April 11, 2017
Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case reportTakuya Tsujino, Kiyoshi Takahara, Tomohisa Matsunaga, et al.
Pageof 5